Corprate Profile
| Company | GeneFrontier Corporation | ||||||||
| Established | October 13, 2010 | ||||||||
| Capital | 10 million yen | ||||||||
| Board of Directors |
|
||||||||
| Shareholders | KANEKA Corporation | ||||||||
| Business | 1. Providing innovative research products, services and technologies in protein engineering and drug discovery. - Customized Human Monoclonal Antibody Generation service, partnered with AbD Serotec, a division of MorphoSys AG (Munich, Germany). - PUREfrex™, reconstituted cell-free protein synthesis system. - PUREfrex RD™, ribosome display utilizing PUREfrex™. - Scaffold, an antibody alternative. 2. Development of Monoclonal Antibody Therapeutics. | ||||||||
| Contact | Todai-Kashiwa Venture Plaza Rm#308
5-4-19, Kashiwa-no-Ha, Kashiwa, Chiba 277-0882, JAPAN Phone: +81-4-7137-6301 Facsimile: +81-4-7132-7530 E-mail: contactus@genefrontier.com |